Fatema Rahman, KaziTasin, Md Abtahi2023-07-262023-07-2620222022-11ID 18346023http://hdl.handle.net/10361/19026Cataloged from PDF version of thesis.Includes bibliographical references (pages 42-51).This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.Alzheimer’s disease is a complex, debilitating neurodegenerative disorder, with a rapidly increasing worldwide prevalence. Despite decades of intense research, therapeutics for Alzheimer's disease are still limited to symptomatic treatments that provide only short-term relief. In recent years, a range of new therapies with better precision have emerged; some are at the pre-clinical stage while some have been tested in clinical trials too. The aim of newer therapies it to treat the underlying cause of AD, provide more safety and long term efficacy. Besides, innovative strategies such as artificial intelligence and personalized medicine have also been introduced to provide more targeted treatment based on patient characteristics and genetic makeup. This comprehensive paper will discuss the various emerging therapies for AD including small molecule drugs, gene therapy, stem cell therapy, followed by a glimpse into the knowledge gaps that will guide research into AD therapeutics over the next decade.51 pagesenBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.Alzheimer’s diseaseCognitive dysfunctionArtificial intelligenceGene therapyStem cell therapySmall molecule drugsAlzheimer's disease--TherapyThesis